PAVmed(PAVM)
$1.14-0.06 (-5.42%)
PAVM
PAVmed financials statements
$1.14
At close:-0.06 (-5.42%)
Want to see PAVM full AI Analyst Report?
PAVmed (PAVM) Ratios
693 Followers
PAVmed Ratios
PAVM's free cash flow for Q3 2026 was $2.45M. For the 2026 fiscal year, PAVM's free cash flow was increased by $35.00K and operating cash flow was $2.42M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.17 | 0.06 | 0.45 | 1.07 | 10.93 |
| Quick Ratio | 0.16 | 0.05 | 0.44 | 1.06 | 10.86 |
| Cash Ratio | 0.10 | 0.03 | 0.36 | 0.96 | 10.22 |
| Solvency Ratio | 0.03 | 1.09 | -1.07 | -2.01 | -6.63 |
| Operating Cash Flow Ratio | -0.35 | -0.95 | -0.96 | -1.72 | -5.37 |
| Short-Term Operating Cash Flow Coverage | -0.47 | -1.15 | -1.18 | -2.11 | 0.00 |
| Net Current Asset Value | $ -13.96M | $ -35.53M | $ -32.64M | $ 880.00K | $ 75.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 1.04 | 1.47 | 0.68 | 0.00 |
| Debt-to-Equity Ratio | 0.39 | -12.77 | -0.91 | -3.78 | 0.00 |
| Debt-to-Capital Ratio | 0.28 | 1.08 | -9.54 | 1.36 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | -12.29 | -0.62 | -5.58 | 1.41 |
| Debt Service Coverage Ratio | -0.21 | 1.02 | -1.69 | -2.85 | 0.00 |
| Interest Coverage Ratio | -1038.38 | -988.60 | -116.80 | -71.11 | 0.00 |
| Debt to Market Cap | 2.50 | 4.79 | 1.48 | 0.79 | 0.00 |
| Interest Debt Per Share | 19.94 | 98.96 | 204.58 | 191.56 | 0.00 |
| Net Debt to EBITDA | -5.04 | 1.03 | -0.38 | 0.03 | 1.38 |
| Profitability Margins | |||||
| Gross Profit Margin | -354.93% | -101.60% | -161.83% | -858.62% | -17.00% |
| EBIT Margin | -3447.89% | 950.65% | -3208.56% | -27044.30% | -11225.20% |
| EBITDA Margin | -3300.00% | 990.65% | -3088.99% | -26392.57% | -11180.00% |
| Operating Profit Margin | -30712.68% | -1485.38% | -2805.67% | -24161.01% | -10878.60% |
| Pretax Profit Margin | -3477.46% | 949.15% | -3232.59% | -27384.08% | -11225.20% |
| Net Profit Margin | 564.79% | 1328.58% | -2617.25% | -23602.92% | -10069.40% |
| Continuous Operations Profit Margin | -3477.46% | 949.15% | -3232.59% | -27384.08% | -11225.20% |
| Net Income Per EBT | -16.24% | 139.98% | 80.96% | 86.19% | 89.70% |
| EBT Per EBIT | 11.32% | -63.90% | 115.22% | 113.34% | 103.19% |
| Return on Assets (ROA) | 1.03% | 129.78% | -193.77% | -164.84% | -57.89% |
| Return on Equity (ROE) | 1.18% | -1594.83% | 119.22% | 919.15% | -81.64% |
| Return on Capital Employed (ROCE) | -90.95% | 929.52% | 326.69% | -712.73% | -68.49% |
| Return on Invested Capital (ROIC) | -61.17% | -179.19% | -278.44% | -191.48% | -68.49% |
| Return on Tangible Assets | 1.03% | 129.78% | -202.48% | -176.08% | -59.27% |
| Earnings Yield | 9.03% | 655.44% | -215.40% | -208.12% | -26.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.73 | 166.39 | 40.20 | 22.18 | 2.50 |
| Payables Turnover | 0.48 | 9.19 | 3.59 | 1.34 | 0.18 |
| Inventory Turnover | 1.35 | 22.70 | 11.91 | 13.85 | 1.11 |
| Fixed Asset Turnover | 0.03 | 1.13 | 0.41 | 0.07 | 0.32 |
| Asset Turnover | 0.00 | 0.10 | 0.07 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | -0.00 | -0.10 | -0.18 | 0.01 | 0.01 |
| Cash Conversion Cycle | -418.97 | -21.44 | -61.82 | -230.27 | -1584.16 |
| Days of Sales Outstanding | 77.11 | 2.19 | 9.08 | 16.46 | 146.00 |
| Days of Inventory Outstanding | 270.08 | 16.08 | 30.64 | 26.36 | 328.19 |
| Days of Payables Outstanding | 766.16 | 39.72 | 101.54 | 273.09 | 2058.35 |
| Operating Cycle | 347.19 | 18.27 | 39.72 | 42.82 | 474.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -7.76 | -104.07 | -215.87 | -358.61 | -235.64 |
| Free Cash Flow Per Share | -7.81 | -104.24 | -216.87 | -366.39 | -244.17 |
| Dividend Paid and CapEx Coverage Ratio | -167.94 | -610.07 | -215.02 | -46.09 | -27.63 |
| Capital Expenditure Coverage Ratio | -167.94 | -610.07 | -215.02 | -46.09 | -27.63 |
| Operating Cash Flow Coverage Ratio | -0.39 | -1.05 | -1.07 | -1.94 | 0.00 |
| Operating Cash Flow to Sales Ratio | -73.32 | -11.20 | -21.22 | -188.29 | -81.18 |
| Free Cash Flow Yield | -117.99% | -553.61% | -175.46% | -169.62% | -22.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.18 | 0.19 | -0.46 | -0.48 | -3.79 |
| Price-to-Sales (P/S) Ratio | 62.51 | 2.03 | 12.15 | 113.41 | 381.38 |
| Price-to-Book (P/B) Ratio | 0.13 | -2.43 | -0.55 | -4.42 | 3.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.85 | -0.18 | -0.57 | -0.59 | -4.53 |
| Price-to-Operating Cash Flow Ratio | -0.85 | -0.18 | -0.57 | -0.60 | -4.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.00 | 0.01 | -0.01 | 0.37 |
| Enterprise Value Multiple | -6.93 | 1.24 | -0.78 | -0.40 | -2.03 |
| Enterprise Value | 16.25M | 36.75M | 58.88M | 39.65M | 113.43M |
| EV to EBITDA | -6.93 | 1.24 | -0.78 | -0.40 | -2.03 |
| EV to Sales | 228.85 | 12.27 | 24.01 | 105.17 | 226.86 |
| EV to Free Cash Flow | -3.10 | -1.09 | -1.13 | -0.55 | -2.70 |
| EV to Operating Cash Flow | -3.12 | -1.10 | -1.13 | -0.56 | -2.79 |
| Tangible Book Value Per Share | 33.26 | -21.81 | -105.55 | 37.83 | 449.26 |
| Shareholders’ Equity Per Share | 50.66 | -7.74 | -223.32 | -48.91 | 357.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.11 | 9.29 | 10.17 | 1.90 | 2.90 |
| Net Income Per Share | 0.60 | 123.42 | -266.23 | -449.53 | -292.28 |
| Tax Burden | -0.16 | 1.40 | 0.81 | 0.86 | 0.90 |
| Interest Burden | 1.01 | 1.00 | 1.01 | 1.01 | 1.00 |
| Research & Development to Revenue | 63267.61 | 1.98 | 5.82 | 67.21 | 39.69 |
| SG&A to Revenue | 241788.73 | 12.07 | 12.62 | 109.84 | 51.13 |
| Stock-Based Compensation to Revenue | 24.04 | 2.15 | 4.54 | 51.81 | 30.02 |
| Income Quality | 2.11 | -1.18 | 0.66 | 0.69 | 0.72 |
Currency in USD
